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Mutation of potential phosphorylation sites has also been used to examine the relationship between phosphorylation and MOPr internalization. Mutation of S375 to Alanine (A) slowed internalization but mutation of S363 and T370 did not (El Kouhen et al., 2001; Schulz et al., 2004) , suggesting S375 is important for β -arrestin recruitment and endocytosis. Mutation of potential S/T phosphorylation sites in the 375-379 region slowed internalization by DAMGO but mutating the 354-357 region did not. Just et al. (2013) reported that mutation of S363, T370 and S375 to A (3S/T-A) partially inhibited agonist-induced internalization but additional mutation of T376, T379 and T383 (6S/T-A) abolished internalization, as did mutation of all C-terminal S and T residues (11S/T-A). These findings strongly suggest that multiple residues in the vicinity of S375 must be phosphorylated for efficient internalization, presumably because they are required for β -arrestin recruitment to the MOPr but the effects of these mutations on desensitization is unknown.
Rapid MOPr desensitization of MOPr coupling to membrane effectors such as voltage-gated calcium channels (VGCCs) and inwardly rectifying K channels (GIRKs, Kir3.X) precedes internalization but its relationship to phosphorylation events and arrestin recruitment is unclear (Dang and Christie, 2012; Williams et al., 2013 Dang et al., (2009) suggested that inhibition of both β -arrestindependent and ERK-dependent mechanisms drive desensitization by ME.
In the present study we examined desensitization of MOPr activated GIRK (Kir3.X) conductance in AtT20 cells transfected with the phosphosite mutants described previously (Just et al., 2013) using perforated patch clamp recording, as well as phosphorylation and internalization under the same conditions. Our results show that desensitization by ME is completely abolished in a MOPr mutant having all 11 sites mutated to A (11S/T-A) but was maintained in the other two mutants
(3S/T-A and 6S/T-A). By contrast, morphine-induced desensitization persisted in all mutants and
was inhibited by a PKC inhibitor, supporting previous findings of distinct mechanisms between the internalizing agonists, ME and DAMGO, and non-internalizing agonists such as morphine M O L # 9 8 2 4 4 8 assay. Clones of wild type, 3ST/A, 6ST/A and 11ST/A with similar binding densities were selected for all experiments (4.2, 3.0, 4,4 and 3.5 pmol/mg protein respectively).
MOPr internalization. MOPr internalization was measured using a similar method to that described in Borgland et al. (2003) . Briefly, AtT20 cells stably expressing different mutant HAtagged MOPr were seeded on 10 mm glass coverslips and incubated for 24 hours to achieve ~50% confluence. Cells were incubated for 30 min in serum-free Dulbecco's modified Eagle's medium followed by addition of ME (30 μ M at 37°C). After 30 min, cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 20 min at room temperature and then permeabilized using 0.1% Triton X-100. Cells then were immune-stained with 1:300 dilution of anti-HA antibody (Santa Cruz, 1 hour at room temperature), rinsed in PBS followed by incubation with 1:1000 Alexa Fluor 488-conjugated goat anti-rabbit antibody (Invitrogen, 1 hour at room temperature). Coverslips were then washed 3 × 10 minute with PBS and mounted with Fluormount-G (SouthernBiotech) on glass slides. Images were acquired using Olympus FV300 laser scanning confocal microscope. High-resolution images (optical magnification: 60X; resolution: 1024 × 1024 pixels) were obtained using a 60× oil objective (UPFL). All the software settings including laser intensity, photomultiplier tube voltage and offset remained constant for the same experiment. Single confocal images that included the nucleus and a large area of cytoplasm were taken from cells chosen at random. The mean of fluorescence intensity (mean of gray value, gray values ranging from 0 to 4096) was quantified from the raw 16-bit images using ImageJ (v 1.44p, Wayne Rasband, National Institutes of Health, USA) software. For each image, a line was drawn around the outside of the cell and the number of pixels with intensity above M O L # 9 8 2 4 4 9 threshold was defined as the "total fluorescence" (membrane plus cytoplasm). A second line was drawn inside the cell membrane, 0.5μm from the first line, and the number of pixels with intensity above threshold within this line ("cytoplasm") was measured). "Membrane fluorescence" was defined as total minus cytoplasm fluorescence. The percentage of internalized receptors was estimated as a ratio of [1 -(membrane fluorescence / total fluorescence)] × 100.
Western Blots. Cells were seeded onto poly-L-lysine-coated 60-mm dishes and grown to 80%
confluence. After treatment with either 10 µM morphine or 10 µM ME at 37 o C), cells were lysed in detergent buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 mM NaF, 10 mM disodiumpyrophosphate, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) in the presence of protease and phosphatase inhibitors Complete mini and PhosSTOP (Roche Diagnostics, Mannheim, Germany). Glycosylated proteins were partially enriched using wheat germ lectinagarose beads as described (Schulz et al., 2004 , Koch et al., 2001 . Proteins were eluted from the beads using SDS-sample buffer for 20 min at 45 °C. Samples were split, resolved on 7.5% SDS-polyacrylamide gels, and after electroblotting, membranes were incubated with either anti-pS356/pT357 {4879}, anti-pT370 {3196}, antipS375 {2493}, anti-pT376 {3722} or anti-pT379 {3686} antibodies followed by detection using an enhanced chemiluminescence detection system (Amersham, Braunschweig, Germany). Blots were stripped and incubated again using the phosphorylation-independent anti-HA antibody to ensure equal loading of the gels.
Electrophysiology. For perforated patch recordings, patch pipettes were pulled from borosilicate glass (AM Systems, Everett, WA, USA) having input resistance ranged between 3.5-4.5 MΩ. All data points are plotted as pure GIRK conductance G (nS) using the following calculation:
[I GIRK (-60 mV) -I GIRK (-120 mV)] / 60 mV. The rate of µ-opioid receptor desensitization and its recovery was calculated as a percentage by using the following formula: (Post G ME / Pre G ME )*100. Where, "Pre" and "Post G ME " are values of GIRK conductance averaged for 4-5 points during the maximal response (coloured points in figures), in response to probe ME (10nM). Comparisons of desensitization for different mutants were analysed using the Kruskal Wallis test. Comparison for heterologous desensitization at SST receptors was analysed using one way ANOVA followed by Dunnett's multiple comparison test. The desensitization and recovery for different µ-opioid receptor mutants were analysed using a two-factor ANOVA followed by Bonferroni post-hoc tests.
Drugs and chemicals. Somatostatin, ME and protein kinase C blocker Calphostin C and amphotericin B were obtained from Sigma-Aldrich (Australia), Staurosporine from Tocris Biosciences, morphine HCl was from GlaxoSmithKline (Boronia, Victoria, Australia).
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Receptor internalization was studied in all MOPr mutants using a full agonist (30 µM ME) at 37 o C and was consistent with our previously reported results in HEK293 cells (Just et al., 2013) .
The images in Figure 1 show that incubation of MOPr and the 3S/T-A mutants with ME (30 μ M)
for 30 min produced internalization, as previously reported (Just et al., 2013 ; 65 ± 2 % internalized in wild type MOPr and 67 ± 4 % in 3S/T-A, n = 7 for each). As previously reported (Just et al., 2013) , incubation of 6S/T-A and 11S/T-A with ME (30 μ M) did not produce significant internalization (% internalization < 5 % in 6S/T-A and 11S/T-A, n = 7 for each). shows the basal conductance (grey) and increased conductance in response to ME (red). Agonistinduced GIRK conductance increases were calculated at 2 s intervals using the voltage step protocol shown in Figure 2A (blue trace), the chord conductance 'G' was plotted during application of agonists as shown in Figure 2B . Conductance increases ( Figure 2B , red circles)
were normalized to the response produced by a supramaximal concentration of somatostatin et al., 2003) in the same cell and concentration-response curves determined as shown in Figure 2C , which shows that morphine acts as a partial agonist compared with ME and SST. As widely reported (Williams et al., 2001 ), MOPr and other G icoupled GPCRs usually converge on a single population of GIRK channels in a single cell. We
confirmed that this was the case for MOPr and natively expressed SST receptors. SSTR types1-4 are natively expressed in AtT20 cells (Patel et al., 1994; Atwood et al., 2011) . A supramaximal concentration of SST (1µM) was applied to MOPr transfected cells for 1 min followed by coapplication of a supramaximal concentration of ME (10µM) as shown in figure 2D . No additional response to ME was observed when co-applied with SST (n = 5) showing that both receptors (SSTR2 and MOPr) activate a common population of GIRK channels.
MOPr desensitization by ME requires multiple phosphorylation sites. Figures 3A and 3B
show representative Western blots and densitometry of the time course of MOPr phosphorylation induced by ME in AtT20 cells. Results were similar to our previous results in HEK293 cells (Doll et al., 2011; Just et al., 2013) . ME-induced maximal receptor phosphorylation of S375 within 20 s, with maximal phosphorylation of T370 and T379 occurring within to 1 min.
S356/T357 and T376 were not maximally phosphorylated until exposed to ME for 20-30 min. It should be noted that the slow phosphorylation of S356/T357 could be due, in part to our finding that the phosphosite antibody {4879} recognizes the epitope only when both sites are phosphorylated (data not shown).
The time course of desensitization during exposure to ME (10 μ M) for 6 min did not correlate with the time course of MOPr phosphorylation ( Figures 3C and 3D) . A very rapid component of desensitization of the GIRK conductance was observed during exposure to supramaximal concentrations of ME which reached a plateau within 6 s (34 ± 3 % decline in the 6s after peak response, n = 11; Figure 3C ). The very rapid component of desensitization was not related to S/T M O L # 9 8 2 4 4 1 4 phosphorylation because it persisted in all mutants exposed to ME (see below). It resembles the rapid non-enzymic direct regulation of GIRK by GRK2 reported by Raveh et al. (2010) . Figure   3C shows a representative example of the time course of desensitization of MOPr coupling to GIRK. Excluding this initial 6 s component, there was a modest decline in the response to the supramaximal concentration of ME (10 μ M) during the 6 min exposure (20 ± 3 %, n = 10), but this measure of desensitization is very insensitive for high intrinsic efficacy agonists such as ME, particularly when there is considerable receptor reserve (Connor et al., 2004) . Exposure to a submaximal or 'probe' concentration of agonist is the most reliable approach to determine desensitization (Connor et al., 2004) . MOPr desensitization was therefore measured by brief exposure to a submaximal probe concentration of ME ( Figure 2C ; 10 nM, 20 s) during and after exposure to a supramaximal concentration of ME (10 μ M, 6 min). A 20s exposure was considered sufficient to washout ME (10 μ M) and achieve a final concentration of ME of 10 nM because we have independently determined the off-rate (τ off ) of ME and morphine by rapid switching to 10 μ M naloxone to be approximately 4s for ME and 3 s for morphine (data not shown), similar to the τ off of ~3 and 2 s, respectively reported by Williams (2014) using caged naloxone in brain slices. Brief (20 s) pre-exposure to a near-maximal concentration of SST (100 nM) was used to normalize MOPr responses due to variation in GIRK expression from cell to cell.
The extent of desensitization was calculated each minute as plotted in Figure 3D . After washout of ME (10 μ M) the response to the probe concentration was 8. point (not shown in Figure 3D ), the time constant for desensitization was ~ 2.6 min. The probe procedure during application of ME (10 μ M) might have slowed the rate of desensitization but did not greatly affect the magnitude because desensitization measured 1 min after washout of 10 μ M ME did not differ when the probe was omitted during desensitization (8.3 ± 0.4 %, n = 5 in presence of probe and 9.6 ± 1.6 %, n = 8 in its absence, P = 0.59, unpaired t-test). 
Mutation of all C-terminal sites (11S/T-A) but not 3S/T-A or 6S/T-A abolishes
desensitization by met-enkephalin. ME-induced desensitization and the rate of recovery from desensitization were measured for wild type MOPr and the three mutants. Figures 5A and B show representative examples of time course of ME-induced desensitization and recovery in wild type MOPr and the 11S/T-A mutant. As introduced above, an initial very rapid GIRK desensitization was observed that reached a plateau in 2-6 s in wild-type MOPr and all mutants (33 ± 3 % decline in wild type MOPr, 33 ± 5 % in 3S/T-A, 37 ± 4 % in 6S/T-A and 26 ± 4 % in 11S/T-A within 6 s exposure to ME, n = 5 for each). Subsequent desensitization of wild type
MOPr during application of ME (10 μ M) was similar to that shown in Figure 3C but no decline
Desensitization by morphine is not disrupted by mutation of S/T phosphorylation sites. As shown in Figure 6 , MOPr desensitization by morphine was unaffected by 3S/T-A, 6S/T-A or 11S/T-A mutations, i.e. mutation of all S/T phosphorylation sites in the C-terminal region of MOPr had no effect on desensitization by morphine. The desensitization during application of morphine (10 μ M) was similar to that shown in Figure 4C for wild type MOPr, 3S/T-A, 6S/T-A and 11S/T-A (34 ± 5 %, 36 ± 1 %, 30 ± 3% and 31 ± 2 % reduction, respectively, n = 4 for each, calculated excluding initial 6 s). The response to the probe concentration of ME (10 nM) 1 min after washout was also unaffected by any of the mutations ( Figure 6C ). The rate of recovery of MOPr function after desensitization with morphine (10µM), for all wild type MOPr and all mutants was more prolonged than recovery from ME-induced desensitization and was also unaffected by any of the mutations ( Figure 6A , B and D, n = 5 for each mutant). These results clearly establish that C-terminal S/T phosphorylation is not required for desensitization by morphine.
PKC inhibition reduces morphine-induced but not met-enkephalin-induced desensitization.
In order to determine if PKC has a role in MOPr desensitization induced by ME and morphine, the effects of several membrane permeable PKC inhibitors were examined. Commonly used, specific PKC inhibitors such GF109203X (1µM) and chelerythrin (1µM) were tested initially but Figure 7E , the blunted desensitization produced by morphine after pre-incubation in calphostin C showed little or no recovery over the ensuing 10 min. By contrast, calphostin C had no effect on ME-induced desensitization or recovery in wild type MOPr or 11S/T-A (Figure 7 B, D and F). Staurosporine (1 µM), a broad range protein kinase inhibitor, including PKC, produced similar inhibition of morphine-induced desensitization in wild type MOPr cells (68 ± 5 %, n = 4).
Met-enkephalin and morphine induce heterologous desensitization at SSTR. In addition to homologous desensitization, heterologous desensitization of SSTRs and α 2 -adrenergic receptors has been previously reported following stimulation of MOPr in LC neurons (Dang et al., 2012; Llorente et al., 2012) . In the present study heterologous desensitization of native SSTR2 responses was observed after 5 min exposure to morphine or ME (10 μ M). Figure 8 A shows that the response to a near maximal concentration of SST (100 nM) the applied at a 6.5 min interval produces no decline in GIRK activation. Figure 8B shows that 5 min exposure to morphine (10 μ M) (B) produces heterologous desensitization of the response to subsequent M O L # 9 8 2 4 4 1 9 application of SST. Figure 8C shows that similar heterologous desensitization of responses to SST was observed following exposure to desensitizing concentrations of either morphine or ME, regardless of whether a submaximal or supramaximal concentration of STT (1 μ M) was used to probe heterologous desensitization.
As shown in Figure 8D (see examples in Figure 5A and B), heterologous desensitization induced by ME was unaffected in 3S/T-A, 6S/T-A and 11S/T-A mutants. Similarly, heterologous desensitization induced by morphine was unaffected in the 11S/T-A mutant (Figure 6A and B;
64 ± 4% of pre-pulse, n = 5 in MOPr versus 61 ± 4%, n = 5 in 11 S/T-A, P = 0.52). Calphostin C (30 nM), did not affect heterologous desensitization induced by ME or morphine in wild type
MOPr (68 ± 5% of pre-pulse, n = 3 for ME and 65 ± 5%, n = 4 for morphine). However, as for morphine-induced desensitization of MOPr, calphostin-C nearly abolished morphine-induced heterologous desensitization in the 11S/T-A mutant (96 ± 3% of pre-pulse, n = 4, P = 0.19 versus pre-pulse) but did not affect ME-induced heterologous desensitization (65 ± 5% of pre-pulse, n = 3).
This article has not been copyedited and formatted. The final version may differ from this version. Based on our findings in HEK293 cells (Just et al., 2013) , the 3S/T-A mutant was expected to produce partial inhibition of ME-induced internalization. The reason for robust ME-induced internalization in the present study is uncertain but might be due to differing patterns of expression of regulatory proteins such as GRKs and arrestins between HEK293 and AtT20 cells (Atwood et al., 2011) . In contrast to morphine, ME-induced heterologous desensitization was unaffected in both wild type MOPr and 11S/T-A, similar to Chu et al. (2010) . In LC neurons, ME-induced heterologous et al., 2012) . This PKC-independent mechanism is unlikely to account for ME-induced heterologous desensitization in the 11S/T-A mutant, which presumably cannot recruit arrestin to MOPr, so the mechanism remains unknown.
In conclusion, the present study has established that C-terminal S/T phosphorylation sites are differentially involved desensitization of MOPr induced by morphine and ME. ME-induced desensitization does not require phosphorylation of sites in the vicinity of S375 that are required for internalization (6S/T-A) but is blocked if all S/T residues are mutated. By contrast, morphine-induced desensitization is partly PKC-dependent and persists when all S/T residues are mutated. Mechanisms involved in PKC-mediated MOPr desensitization by morphine appear to require an interaction of PKC residues in the 354 TSST 357 , S363, T370 or perhaps T394 region.
Mutation of all C-terminal S/T residues does not simply transform the interaction of ME to a morphine-like behaviour that recruits PKC as previously suggested (Zheng et al., 2011) because ME-induced desensitization was insensitive to PKC-inhibition in both the wild-type and 11S/T-A mutants. These findings suggest that differential regulation of MOPr by morphine and strongly internalizing agonists involves multiple mechanisms in addition to differential ability of the agonist occupied receptor to recruit arrestins. Time course of GIRK response to SST (1μM, blue bar) then co-application of SST and ME (10μM, red bar). The extent of desensitization and rate of recovery of response to the probe concentration of ME (10 nM) after desensitization with 10µM morphine in the presence of calphostin C in wild type MOPr (white circles) and 11S/T-A (purple circles, n = 4 per curve). Desensitization and recovery data for wild-type MOPr and 11 S/T-A from Figure 6D are re-plotted as shaded symbols with broken lines for comparison. (F) The extent of receptor desensitization and rate of recovery of response to the probe concentration of ME (10 nM) after desensitization with 10µM ME in the presence of calphostin C in wild type MOPr (white circles) and 11S/T-A (purple circles, n = 4 per curve). Desensitization and recovery data for ME in wild-type MOPr and 11 S/T-A from Figure 5D are re-plotted as shaded symbols with broken lines for comparison. Significant differences between wild type MOPr and 11S/T-A were seen at ***P < 0.001 (Two-way ANOVA, Bonferroni post-tests) (n =4). This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. ST ME ME 10µM ME ME ME ME ME ME ST ME ME ME ME ME ME ME This article has not been copyedited and formatted. The final version may differ from this version. ST ME ME ME ME ME ME GIRK MOPr 2 min 0.2 nS ST ST ST ME ME ME ME ME ME ME 10µM ME 10µM ME This article has not been copyedited and formatted. The final version may differ from this version. ST ST ME ME ME ME ME ME ME 10 mM mrp ME ST ST ME ME ME ME ME ME ME 10 mM mrp ME G ME (% of pre-desens) This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
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